Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Third Harmonic Bio, Inc. - Common Stock (NQ: THRD )

11.04 -0.01 (-0.09%)
Streaming Delayed Price Updated: 11:07 AM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Third Harmonic Bio, Inc. - Common Stock

< Previous 1 2 Next >
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
From Third Harmonic Bio
Via GlobeNewswire
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q4 2023
THRD stock results show that Third Harmonic Bio beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Recap: Third Harmonic Bio Q4 Earnings
Via Benzinga
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio: Q3 Earnings Insights
Via Benzinga
Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Third Quarter 2023 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Leadership Changes
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Second Quarter 2023 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces First Quarter 2023 Financial Results
Company Progresses Preclinical Next-Generation oral KIT Inhibitor for Mast Cell-Mediated Inflammatory Diseases 
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results
Company Progresses Preclinical Next-Generation oral KIT Inhibitor for Mast Cell-Mediated Inflammatory Diseases 
From Third Harmonic Bio
Via GlobeNewswire
Top 5 Health Care Stocks That May Rally
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
5 Cheapest Health Care Stocks You Should Think About
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
5 Cheapest Health Care Stocks You Should Think About
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Top 5 Health Care Stocks That May Surge
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 152 stocks made new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
Via Benzinga
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. 
Via Benzinga
Why Are Airline Stocks Down Today?
Airline stocks are down again on Thursday with downgrades after companies in the sector saw shares drop earlier this week. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Plug Power (PLUG) Stock Represents a $10 TRILLION Opportunity
Plug Power (PLUG) stock is worth checking out on Thursday as one analyst believes the company represents a $10 trillion opportunity. 
Via InvestorPlace
Why Is Third Harmonic Bio (THRD) Stock Down 75% Today?
THRD stock investors are clearly disappointed after Third Harmonic Bio discontinued its clinical study over safety concerns. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 241 companies hit new 52-week lows. 
Via Benzinga
Third Harmonic Bio Stock Plummets After Trial Discontinuation On Safety Concerns
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria
From Third Harmonic Bio
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.